Cytovene · DIN 02162695 · 500 mg/Vial · Pd injection-10mL Pk
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Cytovene · DIN 02162695
Manufacturer: Cheplapharm Arzneimittel GmbH; listing date 2007-01-02
Health Canada: Marketed since 2019-08-09 · brand CYTOVENE · ATC J05AB06 GANCICLOVIR · form Powder for solution · route Intravenous · ingredients GANCICLOVIR (GANCICLOVIR SODIUM) 500 MG/VIAL · company Cheplapharm arzneimittel gmbh · schedule Prescription
Cytovene: Formulary list price $52.23 per unit (the source does not state the unit; exact figure $52.2282). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02162695)
Source record
DIN 02162695: Cytovene
Raw flags: sec3=Y
Item: 081800001; group id 90; item number 0161; lccId None; manufacturer id CHE
Source form: Pd Inj-10mL Pk; strength: 500mg/Vial
Recorded listing: General benefit
Source prices (unrounded): $52.2282; ministry $52.2282
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02162695
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19553
Shortage status: not checked (no credentials)